1. Polygoni Cuspidati Rhizoma et Radix extract activates TFEB and alleviates hepatic steatosis by promoting autophagy.
- Author
-
Li C, Li C, Wang Y, You S, Man KY, Fan Z, Yu Q, Zhang M, Cheng KK, Mok DK, Chan SW, and Zhang H
- Subjects
- Animals, Rats, Male, Humans, Rhizome chemistry, Diet, High-Fat adverse effects, Mechanistic Target of Rapamycin Complex 1 metabolism, Liver drug effects, Liver metabolism, Liver pathology, Lipid Metabolism drug effects, Autophagy drug effects, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors metabolism, Fatty Liver drug therapy, Fatty Liver metabolism, Rats, Sprague-Dawley, Fallopia japonica chemistry, Plant Extracts pharmacology
- Abstract
Hepatic steatosis, characterized by excessive lipid accumulation in the liver, can be ameliorated by autophagy activation. Polygoni Cuspidati rhizome et Radix (PCRR), traditionally used to treat atherosclerosis, hepatitis, and gallstones, has recently demonstrated anti-steatotic effects in the liver. However, the active compounds and underlying mechanisms remain unclear. This study investigated whether PCRR water extract improves steatosis by modulating hepatic autophagic flux. We found that PCRR water extract promoted autophagic flux, enhanced lysosomal biogenesis, and alleviated lipid accumulation in the liver cell lines as well as in the livers of rats with steatosis. Mechanistically, PCRR water extract inhibited mechanistic target of rapamycin complex 1 (mTORC1) activity, leading to dephosphorylation and subsequent nuclear translocation of transcription factor EB (TFEB), a key regulator of lipophagy. TFEB knockdown attenuated PCRR-mediated lipophagy promotion in the liver cell lines. Furthermore, chloroquine (CQ)-mediated autophagy blockage abrogated the therapeutic effect of PCRR against hepatic steatosis in high-fat diet (HFD)-fed rats. These findings suggest that PCRR water extract acts as a novel autophagy enhancer and holds therapeutic potential for hepatic steatosis., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF